NIPT – peace of mind for your baby’s health.
Pregnancy should be a time of joy, not anxiety. Screening tests performed during pregnancy are known as non-invasive prenatal testing (NIPT) – the safest way, from as early as the 10th week of pregnancy for a singleton pregnancy, and from the 12th week of pregnancy for a twin pregnancy, to ensure the foetus is developing normally.
Why choose NIPT?
• Unmatched accuracy: The NIPT test analyses foetal DNA, meaning its accuracy in detecting the most common abnormalities is over 99%. The test assesses the risk of the following syndromes: Down’s syndrome, Edwards’ syndrome, and Patau’s syndrome.
If you want maximum reassurance, we recommend a comprehensive (whole-genome) NIPT. It screens not only the primary chromosomes but also minor structural changes in them that could affect child development (such as Turner’s, Klinefelter’s, DiGeorge, and other syndromes).
• Complete safety: This is simply a routine blood sample taken from your vein. The procedure is 100% safe, carrying no risk to the pregnancy.
• Fast results: You will receive your accurate results, including the baby’s sex (if requested), in just 5 to 10 working days.
Give yourself the opportunity to wait with peace of mind.
Placenta Safe™ Rh – foetal RhD status determination
Placenta Safe™ Rh – a specialised non-invasive prenatal test that allows for the safe and reliable determination of the foetal RhD status. This test is intended for pregnant women with an RhD-negative blood group, if the baby’s father’s blood group is RhD-positive.
myPrenatal 3T – Minimal NIPT for analysis of chromosomes 21, 18, and 13
Detects the three most common foetal chromosomal trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome).
myPrenatal BASIC – Minimal NIPT for analysis of chromosomes 21, 18, and 13
Detects the three most common foetal chromosomal trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome), as well as foetal sex.
Placenta Safe™ 3 – Minimal NIPT for analysis of chromosomes 21, 18, and 13
Detects the three most common foetal chromosomal trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome), as well as foetal sex.
In the case of twin pregnancies, the test determines whether at least one foetus has a trisomy, and whether at least one foetus is male. Sex chromosome abnormalities are not screened in twin pregnancies.
myPrenatal® XY – Basic NIPT with sex chromosome analysis (performed only for singleton pregnancies)
Detects the three primary trisomies, foetal sex, and sex chromosome aneuploidies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), Trisomy 13 (Patau’s syndrome), foetal sex, and sex chromosome aneuploidies.
Placenta Safe™ 5 – Basic NIPT with sex chromosome analysis
Detects the three primary trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome), as well as foetal sex and sex chromosome aneuploidies.
Suitable for singleton and twin monochorionic pregnancies. In the case of twin pregnancies, the test determines whether at least one foetus has a trisomy, and whether at least one is male. Sex chromosome abnormalities are not screened in twin pregnancies.
myPrenatal® Genome – Expanded NIPT with sex chromosome, deletion, and duplication analysis
Detects the three primary trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome), as well as foetal sex, sex chromosome aneuploidies, and large deletions and duplications (>7 Mb).
Placenta Safe™ Plus – Expanded NIPT with sex chromosome, deletion, and duplication analysis
Detects the three primary trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome), as well as foetal sex, sex chromosome aneuploidies, microdeletions, microduplications, and trisomies 9 and 16.
Suitable for singleton and twin monochorionic pregnancies. In the case of twin pregnancies, the test determines whether at least one foetus has a trisomy, and whether at least one is male. Sex chromosome abnormalities are not screened in twin pregnancies.
myPrenatal Karyo – Comprehensive NIPT for all 23 chromosomes with deletion and duplication analysis
Detects the three primary trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome), as well as foetal sex, sex chromosome aneuploidies, large deletions and duplications (>7 Mb), trisomies 9 and 16, and analysis of all chromosomes.
Niptify – Comprehensive NIPT for all 23 chromosomes with deletion and duplication analysis
Detects the three primary trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome), as well as foetal sex, sex chromosome aneuploidies, large deletions and duplications (>7 Mb), microdeletions, microduplications, trisomies 9 and 16, and analysis of all chromosomes.
Performed only for singleton pregnancies.
Placenta Safe™ Karyo Plus – Comprehensive NIPT for all 23 chromosomes with deletion and duplication analysis
Detects the three primary trisomies: Trisomy 21 (Down’s syndrome), Trisomy 18 (Edwards’ syndrome), and Trisomy 13 (Patau’s syndrome), as well as foetal sex, sex chromosome aneuploidies, large deletions and duplications (>7 Mb), microdeletions, microduplications, trisomies 9 and 16, and analysis of all chromosomes.
In the case of twin pregnancies, the test determines whether at least one foetus has a trisomy, and whether at least one is male. Sex chromosome abnormalities and microdeletions are not screened in twin pregnancies.
Placenta Safe™ Gene De Novo – NIPT for analysis of monogenic de novo and inherited conditions
Detects monogenic de novo conditions.
Placenta Safe™ Gene De Novo is a specialised NIPT designed to detect de novo (newly occurring) mutations that can cause syndromic or multi-system conditions. This test is particularly relevant if there is no family history of genetic disorders, but there is a risk of spontaneous genetic changes.
Placenta Safe™ Gene Complete – NIPT for analysis of monogenic de novo and inherited conditions
Detects monogenic de novo conditions and recessive inherited disorders.
Placenta Safe™ Gene Complete is the most comprehensive NIPT for monogenic disorders, covering both de novo mutations and several recessive conditions inherited from parents. This test provides valuable information on foetal genetic health.
Placenta Safe™ Complete Plus – ultimate NIPT for analysis of all 23 chromosomes, deletions, duplications, and genetic disorders
Detects the three primary trisomies, foetal sex, sex chromosome aneuploidies, large deletions and duplications (>7 Mb), microdeletions, microduplications, trisomies 9 and 16, analysis of all chromosomes, monogenic de novo conditions, recessive inherited disorders, and foetal Rhesus (RhD) status.
Placenta Safe™ Full Risk – ultimate NIPT for analysis of all 23 chromosomes, deletions, duplications, and genetic disorders
